Manuel Segovia Hernández-rekin lankidetzan egindako argitalpenak (7)

2015

  1. Differential phenotypic and functional profiles of TcCA-2-specific cytotoxic CD8+ T cells in the asymptomatic versus cardiac phase in chagasic patients

    PLoS ONE, Vol. 10, Núm. 3

2014

  1. The innate immune response status correlates with a divergent clinical course in congenital Chagas disease of twins born in a non-endemic country

    Acta Tropica, Vol. 140, pp. 84-90

2013

  1. Benznidazole treatment reduces the induction of indoleamine 2,3-dioxygenase (IDO) enzymatic activity in Chagas disease symptomatic patients

    Parasite Immunology, Vol. 35, Núm. 5-6, pp. 180-187

2012

  1. Characterization of an immunodominant antigenic epitope from Trypanosoma cruzi as a biomarker of chronic Chagas' disease pathology

    Clinical and Vaccine Immunology, Vol. 19, Núm. 2, pp. 167-173

  2. Trypanosoma cruzi paraflagellar rod proteins 2 and 3 contain immunodominant CD8+ T-cell epitopes that are recognized by cytotoxic T cells from Chagas disease patients

    Molecular Immunology, Vol. 52, Núm. 3-4, pp. 289-298

2011

  1. Identification of HLA-A*02:01-restricted CTL epitopes in Trypanosoma cruzi heat shock protein-70 recognized by Chagas disease patients

    Microbes and Infection, Vol. 13, Núm. 12-13, pp. 1025-1032

  2. Short-term follow-up of chagasic patients after benznidazole treatment using multiple serological markers

    BMC Infectious Diseases, Vol. 11